Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Luo, Yi  [Clear All Filters]
2022
Yan M, Su F, Cheng F, Shi J, Zheng W, Luo Y, Wang J, Lu H, Zhou H, Huang H, et al. Chronic graft-versus-host disease-related polymyositis and myocarditis: A case report and review of the literature. Transpl Immunol. 2022:101598.
Cheng Y-W, Luo Y, Zheng S-J, Xiao J-H. Combination therapy with human amniotic epithelial cells and hyaluronic acid promotes immune balance recovery in type 1 diabetic rats through local engraftment. Scand J Immunol. 2022:e13246.
Wang H, Luo Y, Li J, Guan J, Yang S, Wang Q. Generation of a gene corrected human isogenic iPSC line (CPGHi001-A-1) from a hearing loss patient with the TMC1 p.M418K mutation using CRISPR/Cas9. Stem Cell Res. 2022;60:102736.
Xu L-P, Lu D-P, Wu D-P, Jiang E-L, Liu D-H, Huang H, Sun Z-M, Li N-N, Liu Q-F, Zhang X, et al. Hematopoietic stem cell transplantation activity in China 2020-2021 during the SARS-CoV-2 pandemic: a report from the Chinese Blood and Marrow Transplantation Registry Group. Transplant Cell Ther. 2022.
Zhou J, Chen X, Zhou P, Sun X, Chen Y, Li M, Chu Y, Zhou J, Hu X, Luo Y, et al. Osteopontin is required for the maintenance of leukemia stem cells in acute myeloid leukemia. Biochem Biophys Res Commun. 2022;600:29-34.
Yang T-T, Song X-L, Zhao Y-M, Ye B-D, Luo Y, Xiao H-W, Chen Y, Fu H-R, Yu J, Liu L-Z, et al. Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients. Ann Hematol. 2022.

Pages